Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Psychiatry and Medicine

Stethoscope and pen lying on laboratory result sheet (stock photo) © iStockPhoto

We carry out research at the interfaces between psychiatry and other areas of medicine including research into the treatment of depression in people who are medically ill, the causes of self-harm and suicide and the role of factors such as inflammation and obesity in the development of psychiatric disorders.



Groups within this theme

Our research aims to understand how psychotropic drugs work at molecular level. By exploring this through clinical research in patients we contribute to the development of new evidence-based pharmacological treatments for severe mental illness.
Clinical Psychopharmacology
A Creative Collaborative for Advanced Interdisciplinary Research, Policy & Practice * Underpinned by Methodologies and Critiques from Cultural Psychiatry and Health Inequalities Research * Testing and Evolving Eco-Social, Bio-Psycho-Social, and Syndemic Frameworks
The CHiMES Collaborative
We undertake research across the translational spectrum, ranging from basis science studies, through to trials of new treatments and approaches for psychosis, right through to researching clinical services and their effectiveness. We work closely with the Oxfordshire Early Intervention in Psychosis Service in Oxford Health NHS FT. This service provides high quality, multi-discliplinary care for people experiencing first episode of psychosis and their families. We also lead the Early Intervention Psychosis network for the NHS in the South of England, providing the opportunity to speed up the translation of new research findings into routine clinical care. You can find out more about our current studies below.
Early Psychosis Research Group
We want to understand how best to design a mental health databank which identifies active ingredients in preventing and treating depression and anxiety in young people. We have brought on board young people's voices on how to measure such active ingredients, and how such a databank might be designed, used, and shared. Along with colleagues in Cambridge, we work closely with young people, professionals, and researchers in South Africa and India. We welcome other collaborations and enquiries.
MindKind Study
Nearly a third of dementia cases can be prevented by modifying our lifestyle, in particular our cardiovascular health. While we know that “what’s good for the heart is good for the brain”, we still don’t entirely know why. Our group investigates this heart-brain link in detail, by studying how the health of our heart and large blood vessels affect the brain and memory as we grow older.
Heart and Brain Research
Our mission is to prevent depression and enhance human potential across the lifespan through the therapeutic use of mindfulness.
University of Oxford Mindfulness Research Centre
Centre for Suicide Research
Centre for Suicide Research
A daily and weekly remote symptom monitoring system for patients with over a decade of use in research and clinical service
True Colours

Publications

Publications image

Find all our latest publications here